Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4521.T Stock Summary
Top 10 Correlated ETFs
4521.T
In the News
4521.T Financial details
Company Rating
Strong Buy
Market Cap
137.49B
Income
8.45B
Revenue
73.9B
Book val./share
3657.83
Cash/share
1841.83
Dividend
150
Dividend %
4.09%
Employees
1.16K
Optionable
No
Shortable
Yes
Earnings
01 Aug 2023
P/E
16.63
Forward P/E
-
PEG
-4.6
P/S
1.86
P/B
1
P/C
1.99
P/FCF
-
Quick Ratio
3.63
Current Ratio
5.85
Debt / Equity
0.03
LT Debt / Equity
-
-
-
EPS (TTM)
221.66
EPS next Y
-
EPS next Q
-
EPS this Y
-27.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.78%
Revenue last 5Y
-5.03%
Revenue Q/Q
0.71%
EPS Q/Q
4.19%
-
-
-
-
SMA20
-4.13%
SMA50
-3.29%
SMA100
-3.36%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.13%
Gross Margin
54%
Oper. Margin
26%
Profit Margin
11%
Payout
-
Shs Outstand
37.47M
Shs Float
33.71M
-
-
-
-
Target Price
-
52W Range
3485.0-4075.0
52W High
-9.89%
52W Low
+5.37%
RSI
52.49
Rel Volume
1.6
Avg Volume
82.71K
Volume
132.7K
Perf Week
4.91%
Perf Month
-1.69%
Perf Quarter
-6.45%
Perf Half Y
-4.87%
-
-
-
-
Beta
0.317601
-
-
Volatility
52.13%, 87.38%
Prev Close
1.46%
Price
3672
Change
1.07%
4521.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.43K | 2.36K | 2.28K | 1.94K | 2K | |
Net income per share | 470.55 | 445.78 | 494.89 | 347.37 | 251.44 | |
Operating cash flow per share | 536.27 | 529.89 | 701.79 | 372.64 | 351.15 | |
Free cash flow per share | 489.62 | 476.53 | 645.53 | 313.4 | 265.39 | |
Cash per share | 1.3K | 1.47K | 1.87K | 2K | 1.96K | |
Book value per share | 2.81K | 3.04K | 3.28K | 3.53K | 3.63K | |
Tangible book value per share | 2.81K | 3.04K | 3.28K | 3.53K | 3.43K | |
Share holders equity per share | 2.81K | 3.04K | 3.28K | 3.53K | 3.63K | |
Interest debt per share | 96.15 | 97.61 | 98.8 | 100.21 | 101.82 | |
Market cap | 254.15B | 204.15B | 196.87B | 167.29B | 147.73B | |
Enterprise value | 212.93B | 161.07B | 141B | 107.43B | 90.56B | |
P/E ratio | 13.35 | 11.49 | 10.16 | 12.48 | 15.47 | |
Price to sales ratio | 2.58 | 2.17 | 2.21 | 2.23 | 1.94 | |
POCF ratio | 11.71 | 9.66 | 7.17 | 11.63 | 11.08 | |
PFCF ratio | 12.83 | 10.74 | 7.79 | 13.83 | 14.66 | |
P/B Ratio | 2.23 | 1.69 | 1.53 | 1.23 | 1.07 | |
PTB ratio | 2.23 | 1.69 | 1.53 | 1.23 | 1.07 | |
EV to sales | 2.16 | 1.71 | 1.58 | 1.43 | 1.19 | |
Enterprise value over EBITDA | 7.14 | 5.95 | 4.82 | 5.23 | 4.52 | |
EV to operating cash flow | 9.81 | 7.62 | 5.13 | 7.47 | 6.79 | |
EV to free cash flow | 10.75 | 8.48 | 5.58 | 8.88 | 8.98 | |
Earnings yield | 0.07 | 0.09 | 0.1 | 0.08 | 0.06 | |
Free cash flow yield | 0.08 | 0.09 | 0.13 | 0.07 | 0.07 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | -1.38 | -1.59 | -1.91 | -2.91 | -2.85 | |
Current ratio | 3.35 | 3.76 | 5 | 5.34 | 5.81 | |
Interest coverage | 1.72K | 1.45K | 1.56K | 1.05K | 1K | |
Income quality | 1.14 | 1.19 | 1.03 | 0.77 | 0.96 | |
Dividend Yield | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | |
Payout ratio | 0.32 | 0.34 | 0.3 | 0.43 | 0.6 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.11 | 0.07 | 0.09 | 0.11 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.05 | |
Capex to operating cash flow | -0.09 | -0.1 | -0.08 | -0.16 | -0.24 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | |
Capex to depreciation | -0.89 | -0.99 | -0.95 | -0.99 | -1.31 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.46K | 5.52K | 6.05K | 5.25K | 4.53K | |
ROIC | 0.38 | 0.34 | 0.63 | 0.46 | 0.31 | |
Return on tangible assets | 0.12 | 0.11 | 0.12 | 0.08 | 0.06 | |
Graham Net | 555.36 | 766.4 | 1.28K | 1.5K | 1.45K | |
Working capital | 73.65B | 76.15B | 86.68B | 92.39B | 91.56B | |
Tangible asset value | 113.87B | 121.13B | 128.05B | 135.63B | 130.09B | |
Net current asset value | 66.51B | 68.88B | 78.93B | 86.59B | 83.76B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 11.03B | 11.47B | 9.22B | 8.07B | 7.14B | |
Average inventory | 16.57B | 15.19B | 13B | 13.74B | 15.09B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 105.05 | 97.01 | 72.71 | 90.25 | 62.08 | |
Days of inventory on hand | 143.32 | 124.05 | 115.6 | 162.79 | 158.68 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 3.47 | 3.76 | 5.02 | 4.04 | 5.88 | |
Inventory turnover | 2.55 | 2.94 | 3.16 | 2.24 | 2.3 | |
ROE | 0.17 | 0.15 | 0.15 | 0.1 | 0.07 | |
Capex per share | -46.65 | -53.37 | -56.26 | -59.24 | -85.76 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 525.22 | 478.39 | 475.02 | 486.11 | 489.56 | |
Net income per share | 91.99 | -18.19 | 75.88 | 79.8 | 83.14 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 1.75K | 1.95K | 1.92K | 1.97K | 1.84K | |
Book value per share | 3.63K | 3.6K | 3.58K | 3.65K | 3.66K | |
Tangible book value per share | 3.47K | 3.4K | 3.38K | 3.45K | 3.45K | |
Share holders equity per share | 3.63K | 3.6K | 3.58K | 3.65K | 3.66K | |
Interest debt per share | 100.61 | 100.63 | 100.61 | 100.61 | 100.61 | |
Market cap | 161.28B | 149.02B | 146.15B | 146.15B | 149.02B | |
Enterprise value | 111.76B | 91.84B | 90B | 89.23B | 97.01B | |
P/E ratio | 11.44 | -53.45 | 12.57 | 11.95 | 11.7 | |
Price to sales ratio | 8.02 | 8.13 | 8.03 | 7.85 | 7.95 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 1.16 | 1.08 | 1.06 | 1.05 | 1.06 | |
PTB ratio | 1.16 | 1.08 | 1.06 | 1.05 | 1.06 | |
EV to sales | 5.55 | 5.01 | 4.95 | 4.79 | 5.17 | |
Enterprise value over EBITDA | 22.24 | 28.48 | 20.76 | 21.1 | 21.92 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.02 | 0 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Net debt to EBITDA | -9.85 | -17.73 | -12.95 | -13.46 | -11.75 | |
Current ratio | 5.05 | 5.81 | 5.7 | 5.88 | 5.85 | |
Interest coverage | 1.21K | 1.39K | 1.01K | 1.04K | 1.05K | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.1 | 0.13 | 0.11 | 0.12 | 0.11 | |
Intangibles to total assets | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.74K | 1.21K | 2.47K | 2.56K | 2.62K | |
ROIC | 0.06 | 0.23 | 0.08 | 0.08 | 0.06 | |
Return on tangible assets | 0.02 | 0 | 0.02 | 0.02 | 0.02 | |
Graham Net | 1.24K | 1.44K | 1.42K | 1.48K | 1.35K | |
Working capital | 89.45B | 91.56B | 91.32B | 93.79B | 94.08B | |
Tangible asset value | 133.09B | 130.09B | 129.58B | 132.09B | 132.23B | |
Net current asset value | 83.53B | 83.76B | 83.51B | 86.1B | 86.43B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 7.48B | 6.87B | 6.21B | 6.61B | 7.1B | |
Average inventory | 17.05B | 15.95B | 15.35B | 15.94B | 16.49B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 77.97 | 60.15 | 72.34 | 72.39 | 79.24 | |
Days of inventory on hand | 167.31 | 153.75 | 173.47 | 175.7 | 176.49 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.15 | 1.5 | 1.24 | 1.24 | 1.14 | |
Inventory turnover | 0.54 | 0.59 | 0.52 | 0.51 | 0.51 | |
ROE | 0.03 | -0.01 | 0.02 | 0.02 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
4521.T Frequently Asked Questions
What is Kaken Pharmaceutical Co., Ltd. stock symbol ?
Kaken Pharmaceutical Co., Ltd. is a JP stock and trading under the symbol 4521.T
What is Kaken Pharmaceutical Co., Ltd. stock quote today ?
Kaken Pharmaceutical Co., Ltd. stock price is $3672 today.
Is Kaken Pharmaceutical Co., Ltd. stock public?
Yes, Kaken Pharmaceutical Co., Ltd. is a publicly traded company.